Legal 500
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • News & Developments
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • News & Developments
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Data Protection policies
  • Cookies Policy
  • Supplier Code of Conduct
  • Modern Slavery and Human Trafficking Statement
  • Contact Us
  • home
  • Market Intelligence
  • Search

Your search for ‘Norton Rose Fulbright Australia’ returned 4,177 results

Use advanced search filters to refine your search

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Pharma In Brief - Disclosure Of Clinical Trial And Other Information: Recent Developments In Canada And The EU

    Bill C-17, An Act to Amend the Food and Drugs Act, reported in our earlier Pharma in Brief has now passed through Parliament and was given Royal Assent on November 6, 2014.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Pharma In Brief - Health Canada Seeks Public Input On Drug Shortage Notification

    Two years after the launch of the Canadian Drug Shortage Database, Health Canada is seeking input on the approach to addressing drug shortages in Canada.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Norton Rose Fulbright Canada LLP
Norton Rose Fulbright Canada LLP
  • Article

    Pharma In Brief - Quebec Announces New Reimbursement Rules For Prescriptions Marked "Do Not Substitute"

    On February 12, 2015, Quebec’s Minister of Health and Social Services, Gaétan Barrette, announced new rules regarding the use of the instruction "do not substitute" on innovator drugs.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Pharma In Brief - Report On Pan-Canadian System Of Price Negotiation For Pharmaceuticals Is Released

    The report of consultant, IBM Healthcare, contracted to study the system of pan-Canadian price negotiations, has been publicly released.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Supreme Court Of Canada Recognizes Aboriginal Title Claim In Historic Decision

    The Supreme Court of Canada issued a landmark decision declaring that the Tsilhqot'in First Nation held a valid aboriginal title over a sparsely populated but vast area.
    CanadaGovernment, Public Sector
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Canada To Launch Express Entry Immigration System

    On January 1, 2015, Citizenship and Immigration Canada (CIC) is launching the new Express Entry program.
    CanadaImmigration
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    A Picture Can Be Worth A Thousand Links

    From giant billboards on the highway to tiny pictures that can go viral within seconds, the use of social media sites has revolutionized the advertising industry.
    CanadaIntellectual Property
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Double Brevet – Toujours Pertinent?

    La Loi sur les brevets stipule que le titulaire d'un brevet n'a droit qu'à un brevet pour « une seule invention ». Ce principe d'apparence simple a mené à l'élaboration d'une doctrine complexe dite du « double brevet ».
    CanadaIntellectual Property
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    FORPIQ, À Deux Pas!

    À deux semaines de FORPIQ – le 16 avril, je me permets de vanter l’événement.
    CanadaIntellectual Property
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    IP Monitor - I Went Public With My Invention – Can I Still Get A Patent?

    According to the Canadian <em>Patent Act</em>, to be granted a patent, an invention must not have been "available to the public" before the patent application was filed with the Canadian Patent Office.
    CanadaIntellectual Property
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Legal Considerations For Social Network Application Programming Interfaces

    An application programming interface (API) is a library or structured set of software tools that provides an interface to a backend software platform, such as a social networking platform, without providing direct access to the underlying source code of the platform.
    CanadaIntellectual Property
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Les Brevets Et Le Hockey!

    Ceux qui me connaissent savent que deux de mes passions sont les brevets et le hockey.
    CanadaIntellectual Property
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Quebec Courts Do Not Have Jurisdiction To Hear A Class Action Lawsuit Over The Facebook IPO

    On September 4, 2013, Justice David R. Collier of the Quebec Superior Court dismissed a motion for authorization to institute a class action against Facebook Inc., its directors and the underwriters involved in the Facebook Inc. IPO.
    CanadaLitigation, Mediation & Arbitration
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Novel Tort Of "Publicity Given To Private Life" As Foundation Of A Class Action

    In previous commentaries we have noted that the tort of intrusion on seclusion could form the basis of future class actions in Canada.
    CanadaPrivacy
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Canada Revenue Agency Extends Its Relief Position To "Standard Convertible Debentures"

    To the great satisfaction of lenders and Canadian borrowers, Part XIII of the Income Tax Act (Canada) was amended in 2008 to generally exempt interest payments from Canadian withholding tax.
    CanadaTax
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Thomson Reuters Reports Healthy Global M&A Through Q3 2015

    In its Global M&A Review, for the first nine months of 2015, Thomson Reuters reports healthy global M&A activity leading into the final quarter of fiscal 2015.
    GlobalCorporate/Commercial Law
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    SEC Chair Says SEC Will Propose New Rules On Universal Proxies

    Universal proxies allow shareholders to vote for a combination of management and dissident candidates.
    United StatesCorporate/Commercial Law
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Shareholder Activism Goes Mainstream: Investment Giants Increasingly Focused On Corporate Governance

    The Wall Street Journal reports that Vanguard Group and BlackRock Inc. are becoming more assertive in exercising their influence over companies in which they invest.
    United StatesCorporate/Commercial Law
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    The Effect Of Rising Interest Rates On M&A Activity

    U.S. M&A activity was at peak performance in 2014 as deal activity increased to over 5,051 deals worth $1.5tn U.S., up from 3,995 transactions worth $937bn U.S. in 2013.
    United StatesCorporate/Commercial Law
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Pharma In Brief - Competition Bureau Releases Draft Update To IP Enforcement Guidelines For Public Consultation

    On April 2, 2014, the Competition Bureau released a draft update for public consultation of its Intellectual Property Enforcement Guidelines ("IPEGs").
    CanadaIntellectual Property
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Showing 681–700 of 4177 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics